Last checked at 26 Feb 2010 09:14
| For Immediate Release | 26 February 2010 |
Oxford BioMedica plc ("the Company")
Total Voting Rights Update
In accordance with the FSA's Disclosure and Transparency Rules, Oxford BioMedica plc (LSE:OXB) confirms that as of the date of this announcement the Company's issued share capital consists of 542,917,245 ordinary shares of 1p each, all with voting rights. No shares are held in treasury.
This figure may be used by shareholders as the denominator for the calculation by which they will determine whether they are required to notify their interest in, or a change to their interest in the Company under the FSA's Disclosure and Transparency Rules.
| For further information, please contact: |
|
| Oxford BioMedica plc: John Dawson, Chief Executive Officer Andrew Wood, Chief Financial Officer |
Tel: +44 (0)1865 783 000 |
| JPMorgan Cazenove Limited: James Mitford / Gina Gibson |
Tel: +44 (0)20 7588 2828 |
| City/Financial Enquiries: Lisa Baderoon / Mark Court Buchanan Communications |
Tel: +44 (0)20 7466 5000 |